RankAlpha logo
Back to Rankings

SLDB

Solid BiosciencesF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
SLDB vs peer average
34/100
SLDB vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 2 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CAPR is the first available peer comparator.

Duchenne development comparator, but deramiocel is a different modality. Capricor reported that its FDA target action date was extended to November 22, 2026, creating a nearer regulatory benchmark rather than a like-for-like valuation peer. [Capricor release](https://www.capricor.com/investors/news-events/press-releases/detail/354/capricor-therapeutics-announces-extension-of-pdufa-target)

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCAPRCapricor Therapeutics
SLDB
Solid Biosciences
CAPR
Capricor Therapeutics
Grade
F
F
Momentum
7
4
Value
41
41
Sentiment
45
26
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare top peers (up to 3)

Grade position vs CAPR

SLDB / CAPR
Grade Position
Below peers
SLDB vs. peer average (F vs. D)
34/100
Momentum
7
SLDB
Value
41
SLDB
Sentiment
45
SLDB

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SLDB
1
CAPR
CAPR
F
20/100
Even
2
RGNX
RGNX
C
60/100
+2
3
CRMD
CorMedix Inc Common
A
100/100
+4
4
DBVT
DBV Technologies SA ADR
F
20/100
Even
5
WVE
Wave Life Sciences Inc Common
D
40/100
+1
CAPR is the first peer returned for this comparison set.